News
U.S. bank Wells Fargo has suspended all travel to China after one of its employees was barred from leaving the country, a ...
Groundbreaking findings from Malaysia’s Heart2Miss heart failure screening programme were presented at the European Society ...
U.S. bank Wells Fargo has suspended all travel to China after one of its employees was barred from leaving the country, ...
Astrazeneca (AZN) closed the most recent trading day at $69.26, moving 1.17% from the previous trading session.
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
13h
Zacks Investment Research on MSNAstraZeneca's AL Amyloidosis Drug Misses Goal in Late-Stage StudiesAstraZeneca AZN reported disappointing results from two late-stage studies that evaluated its investigational light chain ...
Following a successful patent defense case upheld by China’s IP authority, AstraZeneca invested nearly 9 billion yuan ($1.24 billion) to establish two global R&D centres in Beijing and Shanghai, said ...
In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a ...
New class of Eureka Fellows selected for their outstanding efforts to build a healthier, more equitable world and will receive support to amplify their sustainability impact in Canada and around ...
29 April 2025 EWHC ruling discusses application of EPO case law regarding lack of plausibility and lack of technical contribution | Court had earlier overturned a first-instance decision allowing an ...
AstraZeneca’s anselamimab has failed to show any benefit in patients with light chain amyloidosis in two Phase III trials. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results